Cantor Colburn , one of the largest full-service IP law firms in the U.S., is the fastest also the growing patent firm over the last ten years. Cantor Colburn is ranked #4 for design patents, #6 for utility patents and #10 for trademarks. The firm’s Litigation Department has also received national recognition. More than 100 attorneys and agents provide counsel to clients worldwide from offices in Hartford, Washington, D.C., Atlanta, Houston, and Detroit. Cantor Colburn is proud to be named one of the Top 100 Firms for Minority Attorneys (IP Law360).
Our Pharmaceutical IP Services Practice Group handles litigation, patent prosecution, inter partes reviews and other Patent Office review proceedings, opinions, landscapes, competitive intelligence, transactional services, portfolio management, biosimilar and interchangeable biological drugs, and more. The Pharmaceutical IP Services Practice Group operates as a team, in which each practice area – patent and litigation – excels at its distinct area, while providing a seamless, one-stop service experience for clients seeking comprehensive pharmaceutical IP services.
With highly specialized knowledge and in-depth understanding of clients' businesses, the firm supports the technological innovations that are driving the world economy.
As a team of chemists and biochemists with many years of experience, Hamm&Wittkopp represents its clients in all areas of intellectual property. One of our strengths lies in the fields of chemistry and pharmaceutics – focusing on generic pharmaceuticals and biosimilars. We offer high-level services, from analysing and clarifying the IP situation, e.g. by oppositions and nullity actions against troublesome patents, to securing your innovations via patent applications and defending your interests in litigations. Our structure allows us to provide tailor-made support in all IP matters, whereby we act with flexibility and efficiency – adapting to the needs of each individual case.
HGF is a leading European intellectual property law firm engaged by companies and research organisations having patents, brands and designs at the core of their business. We provide commercially-relevant, cost-effective advice for IP matters.
HGF advises on the creation of strategic IP assets around the world. HGF provides world-class expertise in the origination, enforcement and defence of IP rights. Our approach is proactive and we work with our clients to find cost-effective, practical solutions to commercial issues.HGF provides:
Locke Lord is a full-service, international law firm of 20 offices designed to meet clients’ needs around the world. The Firm has a history that spans more than 130 years and is a worldwide leader in the middle market sector. Locke Lord advises clients across a broad spectrum of industries including energy, financial services, fund formation, health care, insurance and reinsurance, private equity and venture capital, public finance, real estate, and technology, media and telecommunications, while providing a wealth of experience through its complex litigation, intellectual property, tax, regulatory and transactional teams.
G&B specializes exclusively in intellectual property law, particularly concentrating in patents, trademarks and copyrights. G&B maintains an active docket in all aspects and stages of intellectual property practice, including patent prosecution and licensing, post-grant procedures, litigation, and Hatch-Waxman.
G&B’s Pharmaceutical Practice Group is highly experienced with all aspects of Hatch-Waxman, including developing patent strategies for generic companies, preparing Notice Letters, litigation, and negotiating settlements. Not content to work within rigid confines, G&B attorneys have the flexibility to employ creative methods to resolve disputes, including cooperative and creative negotiations; use of FDA citizen petitions; and post-grant procedures.
Our team is uniquely qualified to represent petitioners and patent owners in Inter Partes Review proceedings (IPR), and Post Grant Review proceedings (PGR). Our team filed the nation’s first PGR petition on a pharmaceutical patent.
Darts-ip is the only global IP case law database with the largest collection of IP cases. As of Jan 2018, we have collected more than 31,50,457 cases from over 3400 courts and IP offices located across 67 Countries, presently with an average upload of 25000 new cases every week! Each individual decision is analysed locally by IP experts and the search interfaces are tailored to the needs of IP professionals.
We aim to help Corporate such as Pharma Companies, Lawyers, Judges, IP Attorneys and In-house Counsels achieve more with case laws. From Anticipation to Litigation, we bring value at every stage of the life of an IP, thereby transforming the way in which people search, find and use case law. Our state-of-the-art tools and filters provide our users with intelligence for legal research, strategic analytics and valuation studies to stay ahead of their competitors.
Singh and Singh Law Firm LLP is a boutique Intellectual Property Law firm offering a comprehensive range of legal services and solutions to clients doing business in India. The firm has years of experience in providing services inter alia in the field of Intellectual Property Law, Media and Telecommunications Laws, Competition Law, Law of Taxation, Drugs Regulatory Laws etc. Founded by Mr. Maninder Singh, Sr Adv, currently Additional Solicitor General of India and Hon’ble Ms. Justice Prathiba M. Singh, Delhi High Court, the firm is professionally managed with 4 partners and over 30 attorneys and patent agents. Highly experienced and qualified individuals make up the respective teams at the firm who have a rich experience in handling intricate and crucial matters.
Amin Talati Upadhye’s Brand to Generic Drug Practice prime focus is strategy and execution. ATU counsels both brand companies [505(b)(2) applicants] seeking to strategically patent and launch their brand name products in the long term; and to generic companies seeking to challenge patents and bring drugs to market. ATU provides input at every stage of the product lifecycle from product selection, R&D, regulatory affairs, product launch, and ongoing marketing/sales. We have great success in court litigations and FDA compliance. The Group is led by Shashank Upadhye, a trusted advisor to companies and widely recognized as one of the leading Hatch-Waxman Paragraph IV attorneys in the country.
LexOrbis is one of the most recommended full service IP firms in India with offices at 3 locations namely, New Delhi, Mumbai and Bangalore. We have a strong team of over 65 attorneys including 46 patent attorneys having expertise in the field of mechanical, electronics, wireless communication, software, mobile applications, chemistry, biotechnology, etc. who are involved in drafting new patent applications originating from India and filing and prosecuting international patent applications. A team of over 19 lawyers at our firm also have deep expertise in handling trademark prosecution and contentious cases. Our patent and trademark attorneys work in combination with our IP litigators to handle a large number contentious IP cases such as pre-and post- grant oppositions, cancellation and infringement suits and criminal enforcement of India rights in India.
Knovos (Previously known as Capital Novus) is an innovative technology provider firm headquartered in Fairfax, VA, Washington, DC. Today Knovos is one of the fastest growing, full-spectrum, and globally recognized E-Discovery and Information Governance & Compliance Technology provider. Being an Industry Pioneer and having a global presence Knovos delivers its solutions to Law Firms, Corporations, and Government Agencies for the past 15 years.
Knovos has developed a range of products which are highly secure, fast, flexible, and reliable.
nayaEDGE™ - For Automated Information Governance, Risk & Compliance,
eZSuite™ – An Integrated eDiscovery Suite from Processing to Production,
eZManage® – Quantifiable Case Management,
Cryptacomm® – Collaborative tool for exchanging critical BI securely and confidentially,
Arbicomm – Arbitration Matter Management
Cascade™ – Outcome based Performance Budgeting Management.
Knovos ensures that projects have seamless, 24x7 project management, consulting services, data hosting, and processing support. our team of Domain experts, highly skilled engineers, project managers and consultants work cohesively to provide valued support to each client matter.
Duane Morris LLP, a law firm with more than 800 attorneys in offices across the United States and internationally, is asked by a broad array of clients to provide innovative solutions to today’s legal and business challenges. Throughout its more than 100-year history, Duane Morris has fostered a collegial culture, where lawyers work with each other to better serve their clients. Lawyers who are leaders in a range of legal disciplines and have diverse backgrounds join Duane Morris in order to use the latest technology, professional support staff and other resources in pursuit of clients’ goals.
As recently reported in an independent study, Taft has one of the busiest Hatch-Waxman and pharmaceutical litigation practices in the United States that focuses nearly exclusively on the representation of generic drug sponsors. The practice group is led by Steve Auten, who has over twenty years of experience, including several years in-house leading the Intellectual Property function for one the largest generic drug companies in the world. Taft also has nationally-recognized attorneys in antitrust, IP licensing, product liability, trademark, and virtually any practice area impacting the pharmaceutical sector. The Taft team is ready to help bring your product to market.
Krishna & Saurastri Associates LLP is an Indian intellectual property and technology law firm recognized as a top tier firm by both Indian and international publications. The firm was formed in 1992 and merged with a law practice set up in 1956. It employs 150 people and has offices in Mumbai, New Delhi, Bangalore, Pune and Ahmedabad. Since inception, the firm has handled matters relating to trademarks, patents, designs, copyrights, plant variety protection, intellectual property licensing, franchising, M&As, JVs, enforcement and anti-counterfeiting, litigation and arbitration, food, drugs and medical device regulations, IT laws, trade secret and data protection, media and entertainment laws, and related techno-legal issues.
Lerner David thrives on what has become unique in the legal world: an IP specialty firm dealing with all aspects of intellectual property. Since 1969, our firm has devoted itself exclusively to IP. Our philosophy of “clients for life” is not a slogan, but rather a demonstrable achievement of which we are most proud.
“When we need someone to really dig in and fight a good fight, we typically turn to Lerner David.” This comment, from a Fortune 100 client, reflects our attention to detail and our focus on achieving, in as efficient a manner as possible, our clients’ business goals. When the stakes are high – as they always are in ANDA litigation – you can count on Lerner David to understand your business, legal, and regulatory goals.
Our life sciences practice, involving both ANDAs and 505(b)(2)’s, is varied and complex. Our team members include skilled courtroom advocates and crafty IP strategists, and we bring to bear our backgrounds and advanced degrees in chemistry, organic chemistry, biochemistry, biology, biotechnology, chemical engineering, materials science, genetics, and bacteriology, among others. We can help plan for every stage of a HatchWaxman challenge from Orange Book strategy and FLBs through litigation, post-grant proceedings, and appeal. We have been involved in the blockbuster cases of the past three decades representing some of the world’s most recognized pharma companies.
An established and premier Hatch-Waxman team for nearly 20 years, Schiff Hardin LLP proudly represents many global and India-based pharmaceutical companies in patent litigation. The Firm has represented more than a dozen generic companies on 100+ pharmaceutical products. Regularly acknowledged for its high quality work and deep relationships, Schiff Hardin was recently recognized as a top Clientopia® law firm in BTI’s Industry Power Rankings 2017 for its strong client relationships in the pharmaceutical industry. The Firm was also named one of the top five Hatch-Waxman defense law firms for representing defendants in the most ANDA cases filed since 2015 in Lex Machina’s 2017 Hatch-Waxman/ANDA Litigation Report.
We are a leading firm of Intellectual Property professionals, including UK Chartered and European Patent Attorneys, UK Chartered and European Trade Mark Attorneys and IP Solicitors, based in London. We have been providing specialist advice and IP services to our clients since 1911.
Our Chemistry, Biotechnology and Pharmaceuticals team enjoys an international reputation, and benefits from attorneys and solicitors with a wide range of professional and academic backgrounds. We are proud to represent a large number of companies within the pharmaceutical and biotechnology industry, including Indian companies, on contentious and non-contentious matters touching on every stage of the product life-cycle.
“A.A. Thornton & Co.’s level of service is ‘outstanding’ – ‘timeliness and appropriateness of advice are a constant’ according to clients, who rate the level of scientific knowledge displayed by the partners and associate lawyers as ‘excellent’ (Legal 500 2017).
Green Griffith focuses exclusively on IP issues involving pharmaceuticals, chemistry and biotechnology—specializing in litigation. Our attorneys share decades of litigation experience assisting both generics and brand companies navigate the Hatch-Waxman Act. As stated in AIM Patent 1000 (2017): “Green, Griffith is a uniquely talented and experienced intellectual property firm that has been making serious waves in the biopharmaceutical market. As for the Green, Griffith modus operandi, they are tirelessly committed to helping their clients succeed; collaborating with their clients as strategic partners – albeit partners who happen to be excellent at litigation.”
Acknowledged leaders in our field, we partner with our clients to provide strategic formulation development and litigation counseling concerning IP and FDA exclusivity issues affecting 505(b)(1), 505(b)(2) and ANDA applications. Pre-litigation, we provide strategies and opinions on API and excipient selection, trade dress, formulation attributes and labeling. Our trial attorneys—who have hard science backgrounds in chemistry, biology and/or biotechnology—then work with each client to execute the desired strategy—whether this involves litigation in the federal courts or IPR practice before the PTAB.
Goldberg Segalla is one of the largest and fastest-growing law firms headquartered in the United States. With nearly 350 attorneys in 20 offices strategically located in New York, Chicago, Philadelphia, Miami, and other major business and economic centers, we serve clients from a wide range of industries in matters across the U.S. and around the globe.
Pharmaceutical companies count on the combined real-world and legal experience of our Intellectual Property team, which counsels clients on all aspects of Abbreviated New Drug Applications (ANDAs) and routinely represents and advises them on pre-litigation strategies, FDA approval, prior art analysis and opinions, Paragraph IV certifications, trials, and appeals.
Established in 1827, Remfry & Sagar has pioneered IP law in India. Its dynamic team of 95 lawyers and 145 professional staff offers services across the full spectrum of intellectual property law with equal competence in prosecution and litigation. 8000 clients drawn from diverse industries across 70 countries are testimony to its leading capabilities.
The Firm has strong expertise in the Indian subcontinent that is complemented by its close links with associates across geographies. This facilitates easy fulfillment of a business' global IP needs. Also, the Firm’s continual engagement with policy makers ensures seamless IP solutions for its clients and contributes towards a larger change in India’s IP milieu.
Remfry & Sagar’s principal office is in Gurugram with branch offices in Chennai and Bengaluru.
RMMS is a full-service litigation and intellectual property law firm with nearly 40 attorneys devoted exclusively to the pharmaceutical industry, including specialty practice in the field of patent and regulatory counseling and litigation under the Hatch-Waxman Act, the Medicare Prescription Drug, Improvement, and Modernization Act (MMA), and the Biologics Price Competition and Innovation Act (BPCIA). The majority of our attorneys have technical degrees or backgrounds in a variety of disciplines, including chemistry, biochemistry, molecular biology, genetics, bioengineering, chemical engineering and pharmacy.
Our experience is unparalleled in the industry. Since the firm’s inception in 2004, RMMS has handled over 300 Hatch-Waxman/BPCIA and related pharmaceutical litigation matters (including declaratory judgment, patent infringement, Administrative Procedure Act (APA), and commercial dispute matters) involving at least 160 different drug products for over 25 pharmaceutical clients. In addition to our substantial litigation experience, our attorneys also have extensive regulatory and legislative experience.